Transfection of dendritic cells (DCs) with the CIITA gene: Increase in immunostimulatory activity of DCs

Cancer Gene Therapy

Volumn 8, Issue 3, 2001, Pages 211-219

  Märten, Angela ^a   Ziske, Carsten ^a   Schöttker, Björn ^a   Weineck, Silvia ^a   Renoth, Sabine ^a   Buttgereit, Peter ^a   Schakowski, Frank ^a   König, Sven ^b   Von Rücker, Alexander ^a   Allera, Axel ^a   Schroers, Roland ^c   Sauerbruch, Tilman ^a   Wittig, B ^b   Schmidt Wolf, Ingo G H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Co stimulatory mol cules; Dendritic cells; MHC class II; NK cells; T cells

Indexed keywords

HLA DM ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY TEST; DENDRITIC CELL; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

ADENOVIRIDAE;

EID: 0035053172     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700292     Document Type: Article

References (30)

1. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms
2. Dendritic cells and the control of immunity
3. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
4. Phenotypic characterization and identification of effector cells involved in tumor recognition of cytokine-induced killer cells
5. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity
6. Propagation of large numbers of T cells with natural killer cell markers
7. Increase of proliferation rate and enhancement of antitumor cytotoxicity of human CD3+CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene
8. Potential of autologous cytokine induced killer cells for bone marrow purging in patients with chronic myeloid leukemia
9. Activated T cells and cytokine-induced CD3+CD56+ killer cells
10. A subset of natural killer cells in peripheral blood displays a mature T-cell phenotype
11. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
12. Comparative studies of CD3- and CD3+CD56+ cells: Examination of morphology, functions, T-cell receptor rearrangement and pore-forming protein expression
13. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency
14. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
15. C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells
16. A role of Ia-associated invariant chains in antigen processing and presentation
17. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading
18. Cathepsin L: Critical role in Ii degradation and CD4 T-cell selection in the thymus
19. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes
20. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants
21. Phase I clinical study applying autologous immunologic effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
22. Dendritic cells: Unique leukocyte populations which control the primary immune response
23. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
24. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
25. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
26. Dendritic cells as adjuvants for immune-mediated resistance to tumors
27. Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9-protein
28. A conditioned dendritic cell can be a temporal bridge between a CD4 T-helper and a T-killer cell
29. Hepatic gene therapy: Efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex
30. Integrins avb3 and avb5 promote adenovirus internalization but not virus attachment